Proposed California Legislation - AB2604

No symptoms in 37% of COVID-19 nursing home patients, research finds6/19

FDA Revokes previous EUA for chloroquine phosphate and hydroxychloroquine sulfate 6/15

CDPH Remdesivir Distribution fact sheet 5/29

Stanford Medicine lead clinical trial of interferon-lambda for COVID-19 5/11

ABIM Increases Flexibility to Maintain Certification4/13

FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment5/1

Earliest known COVID-19 death on February 6 based on autopsy findings   4/23

IDSA Issues Evidence Based Infection Prevention Guidelines 4/27

Current NIH Treatment Guidelines 4/21

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment4/17

FDA has released Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency 4/16

Stryker Recieves EUA for n95 Reprocessing using Vapor Phase H2O2  4/15

Ortho Diagnostics and Chembio Diagnostics recieved EUAs for antibody test kits 4/14

New CDC guidance:  HCP should wear a facemask at all times while they are in the healthcare facility 4/14

IDSA has issued guidance on the treatment and management of patients with COVID-19 4/11

CDC issues guidance on essential employees who may have exposure to COVID-19 4/8

3M Guidance on reprocessing N95 masks 4/7

Red Cross is seeking plasma donations from recovered COVID-19 patients4/6

FDA Issues EUA for COVID-19 Antibody Test (IgM, IgG) to Cellex Inc.4/2

Emergency Use Authorization for Chloroquine From the Strategic Stockpile3/28